Efficacy of intravitreal bevacizumab on diabetic macular oedema in an African population

Kyei, Samuel; Asare, Frederick Afum; Assan, John Kwesi; Zaabaar, Ebenezer; Assiamah, Frank; Obeng, Eric Obour; Asiedu, Kofi

doi:10.1007/s11845-023-03348-z

Cited by 2 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At present, binocular indirect ophthalmoscopy and fundus photography are the tests performed to detect DR among patients reporting to the MPHEC. Evidence suggests that other techniques such as electroretinogram [29,30], optical coherence tomography (OCT), and OCT angiography [10,[30][31][32][33][34] provide additional key features and information for the early and improved diagnosis of DM and DR, as well as monitoring the treatments. These retinal imaging tools could be explored by DR screening centers such as the MPHEC, albeit this would require the training of clinicians and financial investments in the technologies, as previously noted above.…”

Section: Discussionmentioning

confidence: 99%

Patients’ Perspective on Barriers to Utilization of a Diabetic Retinopathy Screening Service

Owusu-Afriyie,

Gende,

Tapilas

et al. 2023

Diabetology

View full text Add to dashboard Cite

This study was conducted to determine the barriers to the utilization of diabetic retinopathy (DR) screening in Papua New Guinea (PNG). A list of patients booked for DR screening at Madang Provincial Hospital Eye Clinic (MPHEC) between January 2017 and December 2021 who had not been screened was retrieved, and the patients were invited to participate in the study. The data were collected using a structured questionnaire, and IBM Statistical Package for Social Sciences version 26 was used for the analysis. p < 0.05 was considered statistically significant. One hundred and twenty-nine patients (37.4%) did not attend DR screening for the period under study. The study response rate was 80.6%. The mean ± SD age of the respondents was 51.5 ± 10.9 years. The majority of the study respondents were female (62.5%), people living in rural settings (53.8%), and farmers (22.1%). Time constraints, poor knowledge about DR, and long waiting periods at the DR screening center were the main barriers to the uptake of DR screening. Compared to respondents in urban communities, those in rural settings were significantly concerned about cost (p < 0.001), travel distance to the MPHEC (p < 0.001), and poor information about DR screening (p = 0.002). More than half of the respondents (63.5%) had discontinued using pharmacotherapy for DM. There is a high rate of nonadherence to diabetes (DM) and DR treatment in PNG. There is a need for public health campaigns about DM and strategic DR screening at the community level in PNG and similar countries.

show abstract